Challenge of improving postoperative pain management: case studies of three acute pain services in the UK National Health Service

Background and aims Medical litigation claim and costs in UK are rising. This study aims to analyse the 10-year trend in litigation costs for individual clinical specialties in the UK from 2009/10 to 2018/19. Methods Data were procured from National Health Service (NHS) Resolution. Number of claims, total litigation costs and cost per claim were ascertained for each financial year. The data collected also includes the number of claims and average amount per claim per speciality during the years 2009–2019 (2009/2010 to 2018/2019 financial years). Results The total annual cost of NHS litigation is currently £3.6 billion(2018/2019). Damages make up the greatest proportion of costs(£1.5 billion). Surgical specialties have the greatest number of claims annually(2847) but Obstetrics has the greatest total litigation(£1.9 billion) and cost per claim(£2.6 million). Number of claims, total costs and cost per claim are significantly greater in 2018/2019 than in 2009/2010. Conclusions Addressing the issue of litigations is complex. Medically there are speciality specific issues that require attention, whilst some general measures are common to all: effective communication, setting realistic targets and maintaining a motivated, adequately staffed workforce. These, alongside legal reforms, may reduce the financial burden of increasing litigation on the NHS.

Download Full-text

Making an impact on health: Medical genetics and the UK National Health Service

The Evolution of Medical Genetics ◽

10.1201/9780429340789-8 ◽

2019 ◽

pp. 183-201

Author(s):

Peter S. Harper

Keyword(s):

National Health Service ◽

Health Service ◽

National Health ◽

Medical Genetics ◽

Uk National Health Service ◽

The Uk

Download Full-text

Pharmacogenomics in the UK National Health Service: opportunities and challenges

Pharmacogenomics ◽

10.2217/pgs-2020-0091 ◽

2020 ◽

Vol 21 (17) ◽

pp. 1237-1246

Author(s):

Richard M Turner ◽

William G Newman ◽

Elvira Bramon ◽

Christine J McNamee ◽

Wai Lup Wong ◽

...

Keyword(s):

National Health Service ◽

Health Service ◽

National Health ◽

Genomic Medicine ◽

Improve Patient Care ◽

Healthcare Sector ◽

Patient Representatives ◽

To Come ◽

Uk National Health Service ◽

The Uk

Despite increasing interest in pharmacogenomics, and the potential benefits to improve patient care, implementation into clinical practice has not been widespread. Recently, there has been a drive to implement genomic medicine into the UK National Health Service (NHS), largely spurred on by the success of the 100,000 Genomes Project. The UK Pharmacogenetics and Stratified Medicine Network, NHS England and Genomics England invited experts from academia, the healthcare sector, industry and patient representatives to come together to discuss the opportunities and challenges of implementing pharmacogenomics into the NHS. This report highlights the discussions of the workshop to provide an overview of the issues that need to be considered to enable pharmacogenomic medicine to become mainstream within the NHS.

Download Full-text